Skip to main content

IDEAYA Biosciences, Inc.

IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001676725

In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding IDEAYA Biosciences, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of IDYA: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders138144+6
Shares56.6M59.7M+3.11M (+5.5%)
Value$1.33B$1.61B+$281.0M (+21.1%)

New holders (18)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to IDYA in Q3 2023
InstitutionSharesValue% of portfolio
Holocene Advisors, LP1,032,931$27.9M0.12%
Eventide Asset Management, LLC335,000$9.04M0.16%
UBS Asset Management Americas Inc270,391$7.30M0.00%
HighVista Strategies LLC126,845$3.42M1.58%
Walleye Capital LLC83,963$2.27M0.03%
Hudson Bay Capital Management LP35,000$944.3K0.01%
SG Americas Securities, LLC21,025$567.0K0.01%
Tudor Investment Corp Et Al20,931$564.7K0.01%
SEI Investments Co16,394$442.3K0.00%
Fred Alger Management, LLC13,470$363.4K0.00%
HSBC Holdings PLC13,399$359.1K0.00%
Squarepoint Ops LLC12,372$333.8K0.00%
Aigen Investment Management, LP8,950$241.5K0.05%
XTX Topco Ltd8,159$220.1K0.04%
Comerica Bank164$4.42K0.00%
Bell Investment Advisors, Inc19$5130.00%
Farther Finance Advisors, LLC5$1350.00%
Covestor Ltd6$00.00%

Sold out (12)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.